Endothelial nitric oxide synthase gene polymorphisms and genetic susceptibility to prostate cancer

European Journal of Cancer Prevention

Volumn 11, Issue 4, 2002, Pages 343-350

  Medeiros, R ^a   Morais, A ^a   Vasconcelos, A ^a   Costa, S ^a   Pinto, D ^a   Oliveira, J ^a   Lopes, C ^a  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

Author keywords

Cancer; EcNOS; Genetic; Nitric oxide; PCR; Prostate; Risk; Susceptibility

Indexed keywords

ASPARTIC ACID; GLUTAMIC ACID; NITRIC OXIDE SYNTHASE;

ADULT; AGED; ALLELE; ANGIOGENESIS; ARTICLE; CANCER GRADING; CASE CONTROL STUDY; CHROMOSOME 7Q; DNA POLYMORPHISM; ENDOTHELIUM CELL; EXON; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR GROWTH; VASCULAR ENDOTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; ENDOTHELIUM; EXONS; GENOTYPE; HUMANS; INTRONS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 0036685839     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-200208000-00005     Document Type: Article

References (48)

1. The effect of androgen on nitric oxide synthase in the male reproductive tract of the rat
2. Kidney and nitric oxide
3. Protein tyrosinase kinase inhibitors decrease induction of nitric oxide synthase activity in LPS-responsive and LPS-nonresponsive murine macrophages
4. Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells
5. Metastasis: Quantitative analysis of distribution and fate of tumor emboli labelled with 125 I-5-iodod-2-deoxyuridine
6. The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis
7. Macrophages and metastasis: A biological approach to cancer therapy: Presidential address
8. Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III)
9. Correlation between circulation cancer cells and incidence of metastases
10. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice
11. Nitric oxide synthases in normal and benign hyperplastic human prostate: Immunohistochemistry and molecular biology
12. Estrogens increase the endothelial nitric oxide synthase (ecNOS) mRNA level in LNCaP human prostate carcinoma cells
13. Castration induces acute vasoconstriction of blood vessels in the rat prostate concomitant with a reduction of prostatic nitric oxide synthase activity
14. Natural killer cells
15. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction
16. Macrophage cytotoxicity: Role for L-arginine deiminase activity and amino nitrogen to nitrate
17. International trends and patterns of prostate cancer incidence and mortality
18. Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: Comparison with enzymatically formed nitric oxide from L-arginine
19. Numerical chromosomal changes in metastatic prostate cancer following anti-androgen therapy: Fluorescence in situ hybridization analysis of 5 Japanese cases
20. Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo
21. Quantitation of 8-oxoguanine and strand breaks produced by four oxidizing agents
22. Selective expression of inducible nitric oxide synthase in human prostate carcinoma
23. Nitric oxide based influence of nitrates on micturition in patients with benign prostatic hyperplasia
24. Nitric oxide synthase gene polymorphisms, blood pressure and aortic stiffness in normotensive and hypertensive subjects
25. Direct in vitro lysis of metastatic tumor cells by cytokine-activated murine vascular endothelial cells
26. Role of nitric oxide in lysis of tumor cells by citokine activated-activated endothelial cells
27. The significance of hematogenous tumor cell clumps in the metastasis process
28. Cloning and structural characterization of the human endothelial nitricoxide-synthase gene
29. Nitric oxide as a carcinogen: Analysis by yeast functional assay of inactivating p53 mutations induced by nitric oxide
30. Nitric oxide as a secretory product of mammalian cells
31. Metastasis suppressor gene(s) for rat prostate cancer on the long arm of human chromosome 7
32. Genetic and chromosomal alterations in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization
33. The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans
34. Antiapoptotic role of endogenous nitric oxide in human melanoma cells
35. Deformability and viability of tumor cells by transcapillary passage with reference to organ affinity in metastasis in cancer
36. Base analog and neighboring base effects on substrate specificity of recombinant human G:T mismatch specific thymine DNA glycosylase
37. Nitric oxide, a macrophage product responsible for cytostasis and respiratory inhibition of tumor target cells
38. Platelet-aggregating activities of metastasising tumor cells. V. In situ roles of platelets in hematogenous metastases
39. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans
40. Tumor-induced platelet aggregation and growth promoting factors as determinants for successful metastasis
41. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene
42. Intact nitric oxide synthase II gene is required for interferon-beta-mediated suppression of growth and metastasis of pancreatic adenocarcinoma
43. Genetic disruption of host nitric oxide synthase II gene impairs melanoma-induced angiogenesis and suppresses pleural effusion
44. B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: A natural hepatic defense against metastasis
45. Biomechanical interactions of cancer cells with the microvasculature during hematogenous metastasis
46. Chemical biology of nitric oxide: Regulation and protective and toxic mechanisms
47. Testing linkage disequilibrium between a disease gene and a marker loci
48. Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease